The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.16BCNY
321.20M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue (TTM)
209.92MCNY
31.22M · vs all stocks (USD)
Updated Aug 21, 2026
Profit Margin
-40.54%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Beta
-0.0800x
vs all stocks
Updated Aug 21, 2026
52-Week Change
-4.69%
vs all stocks
Updated Aug 21, 2026
Market Capitalization
2.16BCNY
321.20M · vs all stocks (USD)
Updated Aug 21, 2026
Enterprise Value
2.15BCNY
320.42M · vs all stocks (USD)
Updated Aug 21, 2026
Price to Sales (TTM)
10.30x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Price to Book (MRQ)
5.40x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Enterprise to Revenue
10.26x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Enterprise to EBITDA
-26.44x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Gross Margin
34.98%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 27.59%.Updated Aug 21, 2026
Profit Margin
-40.54%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Operating Margin
-26.38%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Return on Assets (TTM)
-7.75%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Return on Equity (TTM)
-19.18%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Revenue (TTM)
209.92MCNY
31.22M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue per Share (TTM)
2.77CNYUpdated Aug 21, 2026
Quarterly Revenue Growth
-0.50%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Gross Profit (TTM)
57.92MCNY
8.61M · vs all stocks (USD)
Updated Aug 21, 2026
EBITDA (TTM)
-81.49MCNY
-12.12M · vs all stocks (USD)
Updated Aug 21, 2026
Net Income (TTM)
-85.10MCNY
-12.66M · vs all stocks (USD)
Updated Aug 21, 2026
Quarterly Earnings Growth (YoY)
-37.09%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Operating Cash Flow (TTM)
-57.53MCNY
-8.56M · vs all stocks (USD)
Updated Aug 21, 2026
Levered Free Cash Flow (TTM)
-70.07MCNY
-10.42M · vs all stocks (USD)
Updated Aug 21, 2026
Payout Ratio
0.00%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Minority Interest (Equity)
-111.87KCNYFY2025 · Dec 31, 2025
Revenue
210.14MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
130.70MCNYFY2025 · Dec 31, 2025
Gross Profit
79.44MCNYFY2025 · Dec 31, 2025
Operating Income
-40.97MCNY
-6.09M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-84.33MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-1.92MCNYFY2025 · Dec 31, 2025
Net Income
-82.41MCNYFY2025 · Dec 31, 2025
EBIT
-79.94MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-22.00MCNYFY2025 · Dec 31, 2025
Research & Development
62.14MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
22.92MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
873.75KCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
1.59MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
4.39MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-1.08CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-1.08CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
76.20MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
76.20MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-82.41MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
111.87KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-103.37MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-124.05MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
170.48MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-82.41MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
7.33MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
4.91MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-33.20MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-20.68MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-6.95MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-27.63MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
139.76MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-60.00MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-3.06MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-19.63MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
57.07MCNYFY2025 · Dec 31, 2025
Shares Outstanding
76.00MSharesUpdated Aug 21, 2026
Float Shares
35.42MSharesUpdated Aug 21, 2026
% Held by Insiders
57.93%
vs all stocks
Updated Aug 21, 2026
% Held by Institutions
0.61%
vs all stocks
Updated Aug 21, 2026
Total Cash (MRQ)
154.86MCNY
23.03M · vs all stocks (USD)
Updated Aug 21, 2026
Total Cash per Share (MRQ)
2.05CNYUpdated Aug 21, 2026
Total Debt (MRQ)
189.62MCNY
28.20M · vs all stocks (USD)
Updated Aug 21, 2026
Total Debt to Equity (MRQ)
0.4762x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Current Ratio (MRQ)
2.03x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Book Value per Share (MRQ)
5.27CNYUpdated Aug 21, 2026
Total Assets
708.25MCNY
105.32M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
575.96MCNYFY2025 · Dec 31, 2025
Total Liabilities
296.36MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
132.28MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
29.96MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
266.40MCNYFY2025 · Dec 31, 2025
Cash
170.48MCNYFY2025 · Dec 31, 2025
Cash Equivalents
16.70MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
187.18MCNYFY2025 · Dec 31, 2025
Accounts Receivable
188.37MCNYFY2025 · Dec 31, 2025
Inventory
169.42MCNYFY2025 · Dec 31, 2025
Accounts Payable
96.29MCNYFY2025 · Dec 31, 2025
Short-term Debt
151.80MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
1.00MCNYFY2025 · Dec 31, 2025
Long-term Debt
29.95MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
76.00MCNYFY2025 · Dec 31, 2025
Retained Earnings
-148.31MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
411.89MCNY
61.25M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
10.46MCNYFY2025 · Dec 31, 2025
52-Week Low
22.02CNYUpdated Aug 21, 2026
52-Week High
56.50CNYUpdated Aug 21, 2026
52-Week Change
-4.69%
vs all stocks
Updated Aug 21, 2026
Beta
-0.0800x
vs all stocks
Updated Aug 21, 2026
50-Day MA
32.15CNYUpdated Aug 21, 2026
200-Day MA
34.03CNYUpdated Aug 21, 2026
Avg 10-Day Volume
1.51MSharesUpdated Aug 21, 2026
Avg 30-Day Volume
1.95MSharesUpdated Aug 21, 2026
Diluted EPS (TTM)
-1.12CNYUpdated Aug 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -26.4%, lower than 95% of its Scientific & Technical Instruments peers (median 8.8%)Significant